Goldman Sachs Group Inc Care Dx, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 939,510 shares of CDNA stock, worth $23.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
939,510
Previous 504,770 86.13%
Holding current value
$23.3 Million
Previous $15.8 Million 27.64%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$20.4 - $32.2 $8.87 Million - $14 Million
434,740 Added 86.13%
939,510 $20.1 Million
Q3 2024

Nov 14, 2024
BUY
$14.41 - $33.99 $669,200 - $1.58 Million
46,440 Added 10.13%
504,770 $15.8 Million
Q2 2024

Aug 13, 2024
SELL
$7.56 - $16.15 $543,836 - $1.16 Million
-71,936 Reduced 13.57%
458,330 $7.12 Million
Q1 2024

May 15, 2024
BUY
$7.96 - $12.37 $486,555 - $756,116
61,125 Added 13.03%
530,266 $5.62 Million
Q4 2023

Feb 13, 2024
SELL
$4.9 - $12.86 $810,102 - $2.13 Million
-165,327 Reduced 26.06%
469,141 $5.63 Million
Q3 2023

May 14, 2024
BUY
$7.0 - $11.26 $1.16 Million - $1.86 Million
165,327 Added 35.24%
634,468 $4.44 Million
Q3 2023

Nov 14, 2023
SELL
$7.0 - $11.26 $1.58 Million - $2.53 Million
-225,018 Reduced 26.18%
634,468 $4.44 Million
Q2 2023

May 14, 2024
BUY
$7.61 - $9.46 $968,052 - $1.2 Million
127,208 Added 17.37%
859,486 $7.31 Million
Q2 2023

Aug 14, 2023
BUY
$7.61 - $9.46 $968,052 - $1.2 Million
127,208 Added 17.37%
859,486 $7.31 Million
Q1 2023

May 14, 2024
BUY
$8.83 - $17.61 $2.69 Million - $5.36 Million
304,617 Added 71.23%
732,278 $6.69 Million
Q1 2023

May 11, 2023
BUY
$8.83 - $17.61 $2.69 Million - $5.36 Million
304,617 Added 71.23%
732,278 $6.69 Million
Q4 2022

May 14, 2024
SELL
$10.88 - $20.05 $582,558 - $1.07 Million
-53,544 Reduced 11.13%
427,661 $4.88 Million
Q4 2022

Feb 13, 2023
SELL
$10.88 - $20.05 $582,558 - $1.07 Million
-53,544 Reduced 11.13%
427,661 $4.88 Million
Q3 2022

May 14, 2024
BUY
$16.06 - $26.39 $1.3 Million - $2.14 Million
81,218 Added 20.31%
481,205 $8.19 Million
Q3 2022

Nov 10, 2022
BUY
$16.06 - $26.39 $1.3 Million - $2.14 Million
81,218 Added 20.31%
481,205 $8.19 Million
Q2 2022

May 14, 2024
SELL
$20.49 - $39.72 $1.42 Million - $2.75 Million
-69,154 Reduced 14.74%
399,987 $8.59 Million
Q2 2022

Aug 15, 2022
BUY
$20.49 - $39.72 $196,970 - $381,828
9,613 Added 2.46%
399,987 $8.59 Million
Q1 2022

May 16, 2022
SELL
$28.19 - $46.6 $1.88 Million - $3.11 Million
-66,633 Reduced 14.58%
390,374 $14.4 Million
Q4 2021

Feb 14, 2022
BUY
$41.2 - $73.6 $7.66 Million - $13.7 Million
185,808 Added 68.51%
457,007 $20.8 Million
Q3 2021

Nov 10, 2021
BUY
$59.15 - $91.99 $16 Million - $24.9 Million
271,199 New
271,199 $17.2 Million

Others Institutions Holding CDNA

# of Institutions
222
Shares Held
51.8M
Call Options Held
97.3K
Put Options Held
43.3K
View Full List

About CareDx, Inc.

CDNA Quotes by TradingView
  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.33B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email